Importantly, clinical profile and histopathological analysis were key factors in selecting patients from our study; however, we have as a perspective to include an analysis of ML/DL algorithms trained with specific markers for PSP and EA, different from Tau biomarkers, in order to compare other variables in prediction methods. Here, MAPT is linked to supranuclear palsy, progressive, 1.